GGrantIndex
Sort

40,608 grants matching prostate cancer

Mitigating Cancer Treatment-Related Fatigue by Exercise

$483,183
Johns Hopkins University · R01 · FY2001 · NR

UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK

$483,110
Philip Lazarus · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2008 · DE

Non-coding RNAs for Epigenetic Transcriptional Silencing in Prostate Cancer

$483,031
Martin John Walsh · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · CA

TARGETING GLUTAMINE UTILIZATION IN THERAPY-RESISTANT PROSTATE CANCER

$483,000
Duke University · · FY2021 · Defense Health Agency

Mining Internet Conversation For Evidence Of Herbal Association

$482,925
John H Holmes · University Of Pennsylvania · RC1 · FY2009 · LM

TARGETING THE ONCOGENOMIC FUNCTION OF THE E2F8 TRANSCRIPTION FACTOR IN LETHAL PROSTATE CANCER

$482,890
Duke University · · FY2022 · Department of the Army

Improving breast ultrasound specificity through SFRP2 targeted molecular imaging

$482,737
Paul A Dayton · Univ Of North Carolina Chapel Hill · U01 · FY2017 · CA

Meta-Analysis Systematic and Design Errors: Alcohol Use and Disease Outcomes

$482,717
Kaye M Fillmore · Scientific Analysis Corporation · RC1 · FY2009 · AA

Atlanta Regional Community Clinical Oncology Program (ARCCOP)

$482,599
Thomas E Seay · St. Joseph'S Hospital · U10 · FY2011 · CA

Robot-Assisted Platform for Intratumoral Delivery

$482,547
University Of Rochester · R01 · FY2005 · CA

MDA-7/IL-24: Therapy of Prostate Cancer

$482,536
Paul B Fisher · Virginia Commonwealth University · P01 · FY2008 · CA

G3BP1 Suppresses SPOP Ubiquitin Ligase to Promote Prostate Tumorigenesis

$482,534
Pengbo Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA

PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS

$482,392
University Of Southern California · R01 · FY2002 · CA

PROSTATE CANCER--FAMILY CARE FOR PATIENTS AND SPOUSES

$482,340
University Of Michigan At Ann Arbor · R01 · FY2003 · CA

Interference with Androgen Receptor and Its Ligands

$482,310
James L Mohler · Univ Of North Carolina Chapel Hill · P01 · FY2014 · CA

Project 1: Investigation of immune and stromal factors that promote prostate adenocarcinoma progression and castration response

$482,274
Charles L Sawyers · Columbia University Health Sciences · P01 · FY2024 · CA

Cell and Cancer Biology Branch Confocal Microscopy Core

$482,217
Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA

Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)

$482,155
Xuefeng Liu · Ohio State University · R01 · FY2021 · CA

Development of Drugs That Target Prostate Cancer

$482,004
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Development of Angiogenesis Inhibitors

$482,004
William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA

Tissue/Informatics Core

$481,996
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2008 · CA

The biochemical, topological and functional impact of cancer associated Ctcf mutations and their contribution to cancer

$481,945
Jane Amanda Skok · New York University School Of Medicine · R01 · FY2018 · CA

Development of VN/14-1 and Related Analogs for Breast Cancer Therapy

$481,921
Vincent Collins Ofuka Njar · University Of Maryland Baltimore · R01 · FY2014 · CA

Genetic Epidemiology of Prostate Cancer Aggressiveness

$481,908
John S Witte · University Of California, San Francisco · R01 · FY2008 · CA

A NESTED CASE-CONTROL STUDY OF PROSTATE CARCINOGENESIS

$481,890
Benjamin A. Rybicki · Henry Ford Health System · R01 · FY2016 · ES